Logo
ojaswini cmi3 @go_66a1ea66c061d
Biotech Innovations Set To Boost The Growth Of The Ursodeoxycholic Acid

The ursodeoxycholic acid market is witnessing high growth due to rising prevalence of biliary and liver diseases and expanding applications of ursodeoxycholic acid. According to the PBC Foundation, primary biliary cholangitis affects around 1 in 1,000 women. Innovation in drug delivery systems and development of novel analogs of ursodeoxycholic acid with improved efficacy through biotech interventions are also fueling the market growth. Nanotechnology-enabled formulations that offer targeted release are being explored. Companies are investing in R&D to develop newer ursodeoxycholic acid formulations having applications beyond liver diseases.

Get More Insights On Ursodeoxycholic Acid
https://www.insightprobing...
12:21 PM - Aug 28, 2024 (UTC)

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from ojaswini cmi3, click on at the bottom under it